Cardio Diagnostics - Aset Bersih saben Siji Saham CDIO

The integration of AI tests into medical protocols ensures a steady stream of orders for Cardio Diagnostics. The GURU.Markets system generates this chart, where the net asset value per ordinary share reflects current capitalization, while the 2.53 indicator determines the parameter status. The strategy is based on the diversification of sales channels as management adjusts expenses amid limited liquidity.

Cardio Diagnostics Holdings, Inc. (CDIO) - Nilai Akuntansi saben Saham saka 28.04.2023 nganti 26.10.2026

Ringkesan rincian data analitis Cardio Diagnostics Holdings Inc. (CDIO)

- rega lan prakiraan konsensus rega:

Rega saham Cardio Diagnostics Holdings, Inc.|CDIO - Target median analis

- data kapitalisasi pasar:

Nilai pasar Cardio Diagnostics Holdings|CDIO - Total Nilai Perusahaan

- data kapitalisasi buku:

Aset Bersih saben Siji Saham Cardio Diagnostics|CDIO - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku cardiodiagnosticsinc.com|CDIO - Aset Perusahaan

- data utang lan likuiditas:

Total Utang marang Modal Cardio Diagnostics|CDIO - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal Cardio Diagnostics Holdings, Inc.|CDIO - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Cardio Diagnostics Holdings

Pambiji fundamental perusahaan:Cardio Diagnostics

Produk asil prodhuksi Cardio Diagnostics Holdings Inc.

The deployment of the EpiCheck AI platform for predictive DNA marker analysis forms the foundation of high-tech intangible assets for Cardio Diagnostics (CDIO). The trend in the target book value per share, calculated as the difference between total assets and liabilities divided by the number of shares, reflects the real value of net assets, allowing investors to assess the internal capitalization and resilience of Cardio Diagnostics (CDIO) against potential write-downs.

Pesaing Cardio Diagnostics (CDIO)